Products

Pencilo

AI-native

Fix Grammar. Sound Smarter.

pencilo.app Chrome Web StoreWriting & Documents / Grammar & Proofreading

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$4.17/mo
Lower than 85% of peersNiche median $9/mo
Creators
Nikola Dakic
No social account linked
Launched
15mo ago
2025-09-05 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI Grammar Checker & Paraphraser & Translator

    Sep 5, 2025 · 15mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-05-11

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
$0
Pro
$49.99/yr (billed annually)
20x more usage

Trial: None · 1 paid tier ($49.99) · Observed 2026-11-07 · Source page

Entry price $4.17/mo, Lower than 85% of peers; “Grammar & Proofreading” median is $9/mo.View pricing benchmark

Pages & changes

Tracked since 2025-09-05

Key pages

Weekly snapshots
Home
pencilo.app/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Pencilo cost?
Free: $0; Pro: $49.99/yr (billed annually). Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Pencilo get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Pencilo and what platforms does it support?
Pencilo is catalogued under Grammar & Proofreading: Fix Grammar. Sound Smarter. Supported platforms: Browser Extension.

Related products in this category

Writing & Documents / Grammar & Proofreading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.